Genmab is receiving excessive single-digit and as much as double-digit royalties from the sale of the lung most cancers drug.
发布者：BY MARKETWIRE，转转请注明出处：https://robotalks.cn/jj-receives-expanded-eu-approval-for-genmab-lung-cancer-drug/
J&J receives expanded EU approval for Genmab lung cancer drug
赞 (0)
关于作者
FDA approves insulin pump for new patient group
上一篇
28 8 月, 2024 4:18 上午
Lilly sells Zepbound vials at 50% discount to meet weight loss drug demand
下一篇
28 8 月, 2024 4:18 上午
相关推荐
-
I got my first Homey flows going
I’m thrilled to report that I procured my initial couple of circulations reside in Homey. I linked the Aqara T1 LED light bulb to both Alexa and Homey and have a number of ci…
-
Information for California Customers Affected by Planned Public Safety Power Shutoffs
The golden state’s electrical energies have the capacity to carry out Public Security Power Shutoffs, which momentarily shut off power to certain locations to decrease the da…
-
Suspect in New York insurance executive’s murder pleads not guilty
District attorneys might send out 26-year-old to jail forever for eliminating insurance policy exec. Federal instance might cause capital punishment.
-
Watch Video: “GoAERO Global Emergency Response Flyer Competition Announces USD500,000 of Awards to Global Innovators”
GoAERO and its general reward worth greater than USD2 million for a global competitors to produce Emergency situation Feedback Flyers, has actually introduced lately that 11 Phase …
-
AeroVironment, Inc. to Present at the Jefferies Industrials Conference
ARLINGTON, Va.–(BUSINESS WIRE)–AeroVironment, Inc. (NASDAQ: AVAV) will be participating in the upcoming Jefferies Industrials Conference in New York City, September 5. …
